@article {Balakrishna2021.01.20.21250179, author = {Suraj Balakrishna and Luisa Salazar-Vizcaya and Axel J. Schmidt and Viacheslav Kachalov and Katharina Kusejko and Maria Christine Thurnheer and Jan A. Roth and Dunja Nicca and Matthias Cavassini and Manuel Battegay and Patrick Schmid and Enos Bernasconi and Huldrych F. G{\"u}nthard and Andri Rauch and Roger D. Kouyos and the Swiss HIV Cohort Study (SHCS)}, title = {Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of testing frequency: A modelling study}, elocation-id = {2021.01.20.21250179}, year = {2021}, doi = {10.1101/2021.01.20.21250179}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Over the last decade, syphilis diagnoses among men-who-have-sex-with-men (MSM) have strongly increased in Europe. Understanding the drivers of the ongoing epidemic may aid to curb transmissions.Methods and Findings We set up an epidemiological model to assess the drivers of syphilis in MSM in Switzerland between 2006 and 2017. We stratified the model by syphilis stage, HIV-diagnosis, and behavioral factors to account for syphilis infectiousness and risk for transmission. In the main model, we used {\textquoteleft}reported non-steady partners{\textquoteright} (nsP) as the main proxy for sexual risk. We parameterized the model using data from the Swiss HIV Cohort Study, Swiss Voluntary Counselling and Testing center, cross-sectional surveys among the Swiss MSM population, and published syphilis notifications from the Federal Office of Public Health.The main model reproduced the increase in syphilis diagnoses from 168 cases in 2006 to 418 cases in 2017. It estimated that between 2006 and 2017, MSM with HIV diagnosis had 45.9 times the median syphilis incidence of MSM without HIV diagnosis. Defining risk as condomless anal intercourse with nsP decreased model accuracy (sum of squared weighted residuals, 378.8 vs 148.3). Counterfactual scenarios suggested that increasing screening of MSM without HIV diagnosis and with nsP from once every two-years to twice per year may reduce syphilis incidence (at most 12.8\% reduction by 2017). Whereas, increasing screening among MSM with HIV diagnosis and with nsP from once per year to twice per year may substantially reduce syphilis incidence over time (at least 63.5\% reduction by 2017).Conclusions The model suggests that reporting nsP regardless of condom use is suitable for risk stratification when modelling syphilis transmission. More frequent screening of MSM with HIV diagnosis, particularly those with nsP may aid to curb syphilis transmission.Competing Interest StatementHFG, outside of this study, report grants from Swiss HIV Cohort Study, grants from Swiss National Science Foundation, grants from NIH, grants from Gilead unrestricted research grant, personal fees from Advisor/consultant for Merck, ViiV healthcare and Gilead Sciences and member of DSMB for Merck, grants from Yvonne Jacob Foundation. The institution of MC received research grants from Gilead, ViiV and MSD. All other authors declare no competing interests.Funding StatementThis study was funded by the Swiss HIV Cohort Study under the research grant (Project 823) and by the Swiss National Science Foundation grants (BSSGI0_155851, 177499, and 324730_179567). None of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The SHCS was approved by the local ethical committees of the participating centers: Kantonale Ethikkommission Zurich (KEK-ZH-NR: EK-793); Ethikkommission beider Basel ({\textquoteright}Die Ethikkommission beider Basel hat die Dokumente zur Studie zustimmend zur Kenntnis genommen und genehmigt.{\textquoteright}); Kantonale Ethikkommission Bern (21/88); Comite departmental d{\textquoteright}ethique des specialites medicales es de medecine communautarie et de premier recours, Hopitaux Universitaires de Geneve (01-142); Commission cantonale d{\textquoteright}ethique de la recherche sur l{\textquoteright}etre humain, Canton de Vaud (131/01); Comitato etico cantonale, Repubblica e Cantone Ticino (CE 813); Ethikkommission des Kantons St. Gallen (EKSG 12/003), and written informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe individual level datasets generated or analyzed during the current study do not fulfill the requirements for open data access: 1) The SHCS informed consent states that sharing data outside the SHCS network is only permitted for specific studies on HIV infection and its complications, and to researchers who have signed an agreement detailing the use of the data and biological samples; and 2) the data is too dense and comprehensive to preserve patient privacy in persons living with HIV. According to the Swiss law, data cannot be shared if data subjects have not agreed or data is too sensitive to share. Investigators with a request for selected data should send a proposal to the respective SHCS address (www.shcs.ch/contact). The provision of data will be considered by the Scientific Board of the SHCS and the study team and is subject to Swiss legal and ethical regulations and is outlined in a material and data transfer agreement. However, the numerical data underlying the study are presented in the main manuscript and supplementary information. https://github.com/Kouyos-Group/Suraj_syphilis_repository EMISEuropean Men-Who-Have-Sex-With-Men Internet SurveyFOPHFederal Office of Public HealthHIVHuman immunodeficiency virusIQRInterquartile rangeMSMMen-who-have-sex-with-menMSMwHDMSM with HIV diagnosisMSMw/oHDMSM without HIV diagnosisnsCAICondomless anal intercourse with non-steady partnersnsPnon-steady partnershipSHCSSwiss HIV Cohort StudyVCTVoluntary Testing and Counselling}, URL = {https://www.medrxiv.org/content/early/2021/01/25/2021.01.20.21250179}, eprint = {https://www.medrxiv.org/content/early/2021/01/25/2021.01.20.21250179.full.pdf}, journal = {medRxiv} }